Klarna Group plc stock (KLAR) slides as Trump’s 10% credit-card cap talk jolts lenders, lawsuit deadline looms
12 January 2026
2 mins read

Klarna Group plc stock (KLAR) slides as Trump’s 10% credit-card cap talk jolts lenders, lawsuit deadline looms

New York, Jan 12, 2026, 10:18 (ET) — Regular session

  • Klarna shares dropped roughly 4.8%, slipping to $29.96 in early trading after wrapping up Friday at $31.45.
  • Trump’s plan to cap credit-card interest rates at 10% for one year is sending shockwaves through consumer finance stocks.
  • Investors are keeping an eye on the Feb. 20 deadline for lead plaintiffs in a securities class action linked to an IPO.

Klarna Group plc shares dropped 4.8% to $29.96 in early Monday trading, down from an opening price of $32.33, as investors digested new policy risks tied to U.S. consumer lending and increased legal scrutiny on the recently listed fintech. 1

The shift follows U.S. President Donald Trump’s proposal to cap credit-card interest rates at 10% for one year beginning Jan. 20. Wall Street experts warned that such a wide-ranging cap would almost certainly need Congress approval, with slim chances of making it through. Still, the announcement rattled stocks in lenders and payment companies. 2

A rate cap would slice into one of consumer banking’s most lucrative areas, reshaping who receives credit and under what conditions. Credit card rates currently average around 19.65%, with outstanding balances hitting $1.23 trillion by the end of Q3, according to Bankrate and Federal Reserve figures cited by Reuters. Imposing a cap might steer more borrowers toward alternatives like buy now, pay later plans — short-term installment loans offered at checkout. 3

U.S. financial stocks took a broad hit Monday, though some alternative lending firms fared better. Brian Jacobsen, chief economic strategist at Annex Wealth Management, noted, “When companies can’t price the risk properly, they’ll just reduce credit lines or cut off access to credit entirely. Buy now pay later firms and payday lenders might love this proposal.” Investors will be watching bank earnings reports this week closely for clues on how lenders intend to react. 4

Klarna CEO Sebastian Siemiatkowski threw his support behind the rate-cap proposal, saying the current setup favors wealthier consumers while others face high interest charges. “It’s not a fair system,” Siemiatkowski told The Times. 5

Litigation news has weighed heavily on the stock. Faruqi & Faruqi announced Sunday night that investors have until Feb. 20 to apply to be lead plaintiff in a federal securities class action linked to Klarna’s September 2025 IPO. The lawsuit claims the company and certain executives made misleading statements or left out risks around rising loss reserves. 6

Klarna, the Swedish payments company famous for its BNPL service, went public in New York last September, pricing its shares at $40 each. The stock surged on its first day, according to Reuters. But as of Monday, the shares have fallen sharply, trading well under the IPO price. 7

Credit quality continues to challenge investors. Klarna’s debut earnings as a public company in November revealed revenue growth that surpassed forecasts, yet higher credit loss provisions dragged the shares down, Reuters noted. 8

But the policy headline remains just that — a headline. Without congressional action, the cap might disappear, triggering a swift market reversal. Klarna’s bigger short-term threat is tighter bank credit, which could drive more weak borrowers to BNPL, boosting volumes but also sparking higher defaults and funding costs.

Stock Market Today

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 07.02.2026

7 February 2026
LIVEMarkets rolling coverageStarted: February 7, 2026, 12:00 AM ESTUpdated: February 7, 2026, 12:49 AM EST CSL Faces Growth Uncertainty Amid Seqirus Spin-off Pause and Flu Vaccine Demand Drop February 7, 2026, 12:49 AM EST. CSL (ASX:CSL) confronts near-term challenges after delaying its Seqirus vaccine unit spin-off due to weaker U.S. flu vaccination uptake, impacting its fiscal 2026 growth outlook. Regulatory scrutiny in Europe over its Tavneos kidney therapy data, plus intensifying U.S. competition for its Vifor iron products, heighten concerns over product credibility and pricing pressure. Despite these headwinds, CSL's diversified portfolio in plasma, vaccines, and kidney therapies underpins its
Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Teva stock jumps after $500 million Royalty Pharma deal as investors eye JPM update
Previous Story

Teva stock jumps after $500 million Royalty Pharma deal as investors eye JPM update

Duolingo stock sinks on CFO exit, new finance chief pay package and early Q4 user update
Next Story

Duolingo stock sinks on CFO exit, new finance chief pay package and early Q4 user update

Go toTop